Serpin peptidase inhibitor, clade A member 3 (SERPINA3), is overexpressed in glioma and associated with poor prognosis in glioma patients

References

• PuYLiSZhangCBaoZYangZSunLHigh expression of CXCR3 is an independent prognostic factor in glioblastoma patients that promotes an invasive phenotypeJ Neurooncol20151221435125527046
   PubMed Web of Science ®Google Scholar
• OstromQTGittlemanHFulopJCBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2008–2012Neuro Oncol201517Suppl 4iv1iv6226511214
   PubMed Web of Science ®Google Scholar
• LouisDNOhgakiHWiestlerODThe 2007 WHO classification of tumours of the central nervous systemActa Neuropathol200711429710917618441
   PubMed Web of Science ®Google Scholar
• van den BentMJBrombergJENeuro-oncology: the many challenges of treating elderly glioblastoma patientsNat Rev Neurol201511737437525986504
   PubMed Web of Science ®Google Scholar
• YangPWangYPengXManagement and survival rates in patients with glioma in China (2004–2010): a retrospective study from a single-institutionJ Neurooncol201311325926623483435
   PubMed Web of Science ®Google Scholar
• SantamariaMPardo-SagantaAAlvarez-AsiainLNuclear alpha1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cellsGastroenterology20131444818.e4828.e423295442
   PubMedGoogle Scholar
• ChelbiSTWilsonMLVeillardACGenetic and epigenetic mechanisms collaborate to control SERPINA3 expression and its association with placental diseasesHum Mol Genet20122191968197822246292
   PubMed Web of Science ®Google Scholar
• ZhouJChengYTangLMartinkaMKaliaSUp-regulation of SERPINA3 correlates with high mortality of melanoma patients and increased migration and invasion of cancer cellsOncotarget Epub2016517
   Google Scholar
• YangGDYangXMLuHSERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosisInt J Clin Exp Pathol2014741348135824817931
   PubMed Web of Science ®Google Scholar
• JinYWangJYeXIdentification of GlcNAcylated alpha-1-antichymotrypsin as an early biomarker in human non-small-cell lung cancer by quantitative proteomic analysis with two lectinsBr J Cancer2016114553254426908325
   PubMed Web of Science ®Google Scholar
• KarashimaSKataokaHItohHMaruyamaRKoonoMPrognostic significance of alpha-1-antitrypsin in early stage of colorectal carcinomasInt J Cancer19904522442502303291
   PubMed Web of Science ®Google Scholar
• YamamuraJMiyoshiYTamakiYmRNA expression level of estrogen-inducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancersCancer Sci2004951188789215546506
   PubMedGoogle Scholar
• MontelVPestonjamaspKMoseETarinDTumor-host interactions contribute to the elevated expression level of alpha1-antichymotrypsin in metastatic breast tumor xenograftsDifferentiation2005732–3889815811132
   PubMedGoogle Scholar
• TaharaEItoHTaniyamaKYokozakiHHataJAlpha 1-antitrypsin, alpha 1-antichymotrypsin, and alpha 2-macroglobulin in human gastric carcinomas: a retrospective immunohistochemical studyHum Pathol198415109579646207098
   PubMed Web of Science ®Google Scholar
• JinawathNVasoontaraCJinawathAOncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinomaPLoS One201056e1119820585448
   PubMedGoogle Scholar
• ZelvyteIWallmarkAPiitulainenEWestinUJanciauskieneSIncreased plasma levels of serine proteinase inhibitors in lung cancer patientsAnticancer Res200424124124715015603
   PubMed Web of Science ®Google Scholar
• SongWWangNLiWSerum peptidomic profiling identifies a minimal residual disease detection and prognostic biomarker for patients with acute leukemiaOncol Lett2013651453146024179540
   PubMedGoogle Scholar
• LiebKFiebichBLSchallerHBergerMBauerJInterleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa BJ Neurochem1996675203920448863511
   PubMedGoogle Scholar
• MacheinULiebKHullMFiebichBLIL-1 beta and TNF alpha, but not IL-6, induce alpha 1-antichymotrypsin expression in the human astrocytoma cell line U373 MGNeuroreport1995617228322868747137
   PubMedGoogle Scholar
• FriendlanderAHEttingerRLKarnofsky performance status scaleSpec Care Dentist200929414714819573040
   PubMedGoogle Scholar
• DuanJHuangWShiHPositive expression of KIF20A indicates poor prognosis of glioma patientsOnco Targets Ther201696741674927843327
   PubMed Web of Science ®Google Scholar
• LuoDChenHLuPCHI3L1 overexpression is associated with metastasis and is an indicator of poor prognosis in papillary thyroid carcinomaCancer Biomark Epub20161216
   Google Scholar
• TaylorLPDiagnosis, treatment, and prognosis of glioma: five new thingsNeurology20107518 Suppl 1S28S3221041768
   PubMed Web of Science ®Google Scholar
• DeorahSLynchCFSibenallerZARykenTCTrends in brain cancer incidence and survival in the United States: surveillance, Epidemiology, and End Results Program, 1973 to 2001Neurosurg Focus2006204E1
   PubMedGoogle Scholar
• YanHTianRZhangMWuJDingMHeJHigh expression of long noncoding RNA HULC is a poor predictor of prognosis and regulates cell proliferation in gliomaOnco Targets Ther20171011312028053545
   PubMed Web of Science ®Google Scholar
• SulmanEPGuerreroMAldapeKBeyond grade: molecular pathology of malignant gliomasSemin Radiat Oncol200919314214919464628
   PubMedGoogle Scholar
• LouisDNMolecular pathology of malignant gliomasAnnu Rev Pathol200619711718039109
   PubMed Web of Science ®Google Scholar
• NgHKLoSTImmunostaining for alpha 1-antichymotrypsin and alpha 1-antitrypsin in gliomasHistopathology19881379873264803
   PubMedGoogle Scholar
• KrohHCervos-NavarroJAlpha-1-antichymotrypsin in human glioblastoma multiforme cells and its relation to GFAP immunostainingClin Neuropathol1991101811861653125
   PubMedGoogle Scholar
• EgebladMWerbZNew functions for the matrix metalloproteinases in cancer progressionNat Rev Cancer2002216117411990853
   PubMed Web of Science ®Google Scholar
• RadunovicMNikolicNMilenkovicSThe MMP-2 and MMP-9 promoter polymorphisms and susceptibility to salivary gland cancerJ BUON201621359760227569079
   PubMedGoogle Scholar
• GigantiMGTresoldiISorgeRPhysical exercise modulates the level of serum MMP-2 and MMP-9 in patients with breast cancerOncol Lett20161232119212627602150
   PubMedGoogle Scholar
• LiottaLAKohnECThe microenvironment of the tumour-host interfaceNature200141137537911357145
   PubMed Web of Science ®Google Scholar
• KataokaHItohHKoonoMEmerging multifunctional aspects of cellular serine proteinase inhibitors in tumor progression and tissue regenerationPathol Int2002528910211940213
   PubMedGoogle Scholar
• JungYJKatiliusEOstroffRMDevelopment of a protein biomarker panel to detect non-small-cell lung cancer in KoreaClin Lung Cancer2017182e99e10727836219
   PubMedGoogle Scholar
• TianWLiuJPeiBWangXGuoYYuanLIdentification of miRNAs and differentially expressed genes in early phase non-small cell lung cancerOncol Rep20163542171217626781349
   PubMedGoogle Scholar